115 The frequency of intermediate monocytes before treatment is a candidate biomarker of clinical response to secukinumab in of psoriasis

Autor: J. Hardman-Smart, R. Andres Ejarque, S. Solanky, I. Tosi, K. Grys, J. Barker, C. Griffiths, N.J. Reynolds, C. Smith, R.B. Warren, P. Di Meglio, P. Consortium
Rok vydání: 2022
Předmět:
Zdroj: Journal of Investigative Dermatology. 142:S200
ISSN: 0022-202X
Databáze: OpenAIRE